Global Veterinary Drug Market Growth 2025-2031
The global Veterinary Drug market size is predicted to grow from US$ 27080 million in 2025 to US$ 37780 million in 2031; it is expected to grow at a CAGR of 5.7% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.
The growth of the veterinary drug market is primarily driven by the rising global demand for animal protein, such as meat, milk, and eggs, which necessitates improved animal health and productivity. Increasing pet ownership and heightened awareness of animal welfare are also contributing to greater demand for preventive and therapeutic veterinary treatments. Moreover, advancements in veterinary medicine—such as targeted antibiotics, vaccines, and parasiticides—are helping to address a wide range of animal diseases more effectively. Government initiatives and regulatory support for animal healthcare further strengthen the market, especially in emerging economies with expanding livestock and pet populations.
A major challenge in the veterinary drug market is the growing concern over antimicrobial resistance (AMR) resulting from the overuse and misuse of antibiotics in animals. Regulatory authorities are imposing stricter rules on drug approvals and usage, which can increase development costs and limit market accessibility for certain products. Additionally, the high cost and lengthy process of veterinary drug development—combined with the need for specialized R&D infrastructure—pose significant barriers to entry for smaller firms. Price sensitivity in developing regions and limited access to veterinary care in rural areas also hinder market penetration, particularly for premium or innovative drug formulations.
LP Information, Inc. (LPI) ' newest research report, the “Veterinary Drug Industry Forecast” looks at past sales and reviews total world Veterinary Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Drug sales for 2025 through 2031. With Veterinary Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Drug industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Veterinary Drug market?
What factors are driving Veterinary Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Drug market opportunities vary by end market size?
How does Veterinary Drug break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.
The growth of the veterinary drug market is primarily driven by the rising global demand for animal protein, such as meat, milk, and eggs, which necessitates improved animal health and productivity. Increasing pet ownership and heightened awareness of animal welfare are also contributing to greater demand for preventive and therapeutic veterinary treatments. Moreover, advancements in veterinary medicine—such as targeted antibiotics, vaccines, and parasiticides—are helping to address a wide range of animal diseases more effectively. Government initiatives and regulatory support for animal healthcare further strengthen the market, especially in emerging economies with expanding livestock and pet populations.
A major challenge in the veterinary drug market is the growing concern over antimicrobial resistance (AMR) resulting from the overuse and misuse of antibiotics in animals. Regulatory authorities are imposing stricter rules on drug approvals and usage, which can increase development costs and limit market accessibility for certain products. Additionally, the high cost and lengthy process of veterinary drug development—combined with the need for specialized R&D infrastructure—pose significant barriers to entry for smaller firms. Price sensitivity in developing regions and limited access to veterinary care in rural areas also hinder market penetration, particularly for premium or innovative drug formulations.
LP Information, Inc. (LPI) ' newest research report, the “Veterinary Drug Industry Forecast” looks at past sales and reviews total world Veterinary Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Drug sales for 2025 through 2031. With Veterinary Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Drug industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Anti-Infectives
- Anti-Inflammatory
- Parasiticides
- Analgesics
- Sedatives
- Others
- Pets
- Cattle
- Poultry
- Swine
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Zoetis
- Elanco
- Boehringer Ingelheim
- Merck
- Virbac
- Ceva
- Vetoquinol
- Dechra
- Norbrook
- Phibro
- Huvepharma
- Hipra
- Ouro Fino Saude
- CAHIC
- Orion
- Ringpu Biology
- Nippon Zenyaku Kogyo
- Farmavet-Pasteur
- Jinhe Bio
- Qianjiang Biochemical
What is the 10-year outlook for the global Veterinary Drug market?
What factors are driving Veterinary Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Drug market opportunities vary by end market size?
How does Veterinary Drug break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Veterinary Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Veterinary Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Veterinary Drug by Country/Region, 2020, 2024 & 2031
2.2 Veterinary Drug Segment by Type
2.2.1 Anti-Infectives
2.2.2 Anti-Inflammatory
2.2.3 Parasiticides
2.2.4 Analgesics
2.2.5 Sedatives
2.2.6 Others
2.3 Veterinary Drug Sales by Type
2.3.1 Global Veterinary Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Veterinary Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Veterinary Drug Sale Price by Type (2020-2025)
2.4 Veterinary Drug Segment by Application
2.4.1 Pets
2.4.2 Cattle
2.4.3 Poultry
2.4.4 Swine
2.4.5 Others
2.5 Veterinary Drug Sales by Application
2.5.1 Global Veterinary Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Veterinary Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Veterinary Drug Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Veterinary Drug Breakdown Data by Company
3.1.1 Global Veterinary Drug Annual Sales by Company (2020-2025)
3.1.2 Global Veterinary Drug Sales Market Share by Company (2020-2025)
3.2 Global Veterinary Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Veterinary Drug Revenue by Company (2020-2025)
3.2.2 Global Veterinary Drug Revenue Market Share by Company (2020-2025)
3.3 Global Veterinary Drug Sale Price by Company
3.4 Key Manufacturers Veterinary Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary Drug Product Location Distribution
3.4.2 Players Veterinary Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VETERINARY DRUG BY GEOGRAPHIC REGION
4.1 World Historic Veterinary Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Veterinary Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Veterinary Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Veterinary Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Veterinary Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Veterinary Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Veterinary Drug Sales Growth
4.4 APAC Veterinary Drug Sales Growth
4.5 Europe Veterinary Drug Sales Growth
4.6 Middle East & Africa Veterinary Drug Sales Growth
5 AMERICAS
5.1 Americas Veterinary Drug Sales by Country
5.1.1 Americas Veterinary Drug Sales by Country (2020-2025)
5.1.2 Americas Veterinary Drug Revenue by Country (2020-2025)
5.2 Americas Veterinary Drug Sales by Type (2020-2025)
5.3 Americas Veterinary Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Drug Sales by Region
6.1.1 APAC Veterinary Drug Sales by Region (2020-2025)
6.1.2 APAC Veterinary Drug Revenue by Region (2020-2025)
6.2 APAC Veterinary Drug Sales by Type (2020-2025)
6.3 APAC Veterinary Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Veterinary Drug by Country
7.1.1 Europe Veterinary Drug Sales by Country (2020-2025)
7.1.2 Europe Veterinary Drug Revenue by Country (2020-2025)
7.2 Europe Veterinary Drug Sales by Type (2020-2025)
7.3 Europe Veterinary Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Veterinary Drug by Country
8.1.1 Middle East & Africa Veterinary Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Veterinary Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Veterinary Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Veterinary Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Drug
10.3 Manufacturing Process Analysis of Veterinary Drug
10.4 Industry Chain Structure of Veterinary Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary Drug Distributors
11.3 Veterinary Drug Customer
12 WORLD FORECAST REVIEW FOR VETERINARY DRUG BY GEOGRAPHIC REGION
12.1 Global Veterinary Drug Market Size Forecast by Region
12.1.1 Global Veterinary Drug Forecast by Region (2026-2031)
12.1.2 Global Veterinary Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Veterinary Drug Forecast by Type (2026-2031)
12.7 Global Veterinary Drug Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Veterinary Drug Product Portfolios and Specifications
13.1.3 Zoetis Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Elanco
13.2.1 Elanco Company Information
13.2.2 Elanco Veterinary Drug Product Portfolios and Specifications
13.2.3 Elanco Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Elanco Main Business Overview
13.2.5 Elanco Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Veterinary Drug Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Veterinary Drug Product Portfolios and Specifications
13.4.3 Merck Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Virbac
13.5.1 Virbac Company Information
13.5.2 Virbac Veterinary Drug Product Portfolios and Specifications
13.5.3 Virbac Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Virbac Main Business Overview
13.5.5 Virbac Latest Developments
13.6 Ceva
13.6.1 Ceva Company Information
13.6.2 Ceva Veterinary Drug Product Portfolios and Specifications
13.6.3 Ceva Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Ceva Main Business Overview
13.6.5 Ceva Latest Developments
13.7 Vetoquinol
13.7.1 Vetoquinol Company Information
13.7.2 Vetoquinol Veterinary Drug Product Portfolios and Specifications
13.7.3 Vetoquinol Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Vetoquinol Main Business Overview
13.7.5 Vetoquinol Latest Developments
13.8 Dechra
13.8.1 Dechra Company Information
13.8.2 Dechra Veterinary Drug Product Portfolios and Specifications
13.8.3 Dechra Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Dechra Main Business Overview
13.8.5 Dechra Latest Developments
13.9 Norbrook
13.9.1 Norbrook Company Information
13.9.2 Norbrook Veterinary Drug Product Portfolios and Specifications
13.9.3 Norbrook Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Norbrook Main Business Overview
13.9.5 Norbrook Latest Developments
13.10 Phibro
13.10.1 Phibro Company Information
13.10.2 Phibro Veterinary Drug Product Portfolios and Specifications
13.10.3 Phibro Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Phibro Main Business Overview
13.10.5 Phibro Latest Developments
13.11 Huvepharma
13.11.1 Huvepharma Company Information
13.11.2 Huvepharma Veterinary Drug Product Portfolios and Specifications
13.11.3 Huvepharma Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Huvepharma Main Business Overview
13.11.5 Huvepharma Latest Developments
13.12 Hipra
13.12.1 Hipra Company Information
13.12.2 Hipra Veterinary Drug Product Portfolios and Specifications
13.12.3 Hipra Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Hipra Main Business Overview
13.12.5 Hipra Latest Developments
13.13 Ouro Fino Saude
13.13.1 Ouro Fino Saude Company Information
13.13.2 Ouro Fino Saude Veterinary Drug Product Portfolios and Specifications
13.13.3 Ouro Fino Saude Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Ouro Fino Saude Main Business Overview
13.13.5 Ouro Fino Saude Latest Developments
13.14 CAHIC
13.14.1 CAHIC Company Information
13.14.2 CAHIC Veterinary Drug Product Portfolios and Specifications
13.14.3 CAHIC Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 CAHIC Main Business Overview
13.14.5 CAHIC Latest Developments
13.15 Orion
13.15.1 Orion Company Information
13.15.2 Orion Veterinary Drug Product Portfolios and Specifications
13.15.3 Orion Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Orion Main Business Overview
13.15.5 Orion Latest Developments
13.16 Ringpu Biology
13.16.1 Ringpu Biology Company Information
13.16.2 Ringpu Biology Veterinary Drug Product Portfolios and Specifications
13.16.3 Ringpu Biology Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Ringpu Biology Main Business Overview
13.16.5 Ringpu Biology Latest Developments
13.17 Nippon Zenyaku Kogyo
13.17.1 Nippon Zenyaku Kogyo Company Information
13.17.2 Nippon Zenyaku Kogyo Veterinary Drug Product Portfolios and Specifications
13.17.3 Nippon Zenyaku Kogyo Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Nippon Zenyaku Kogyo Main Business Overview
13.17.5 Nippon Zenyaku Kogyo Latest Developments
13.18 Farmavet-Pasteur
13.18.1 Farmavet-Pasteur Company Information
13.18.2 Farmavet-Pasteur Veterinary Drug Product Portfolios and Specifications
13.18.3 Farmavet-Pasteur Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Farmavet-Pasteur Main Business Overview
13.18.5 Farmavet-Pasteur Latest Developments
13.19 Jinhe Bio
13.19.1 Jinhe Bio Company Information
13.19.2 Jinhe Bio Veterinary Drug Product Portfolios and Specifications
13.19.3 Jinhe Bio Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Jinhe Bio Main Business Overview
13.19.5 Jinhe Bio Latest Developments
13.20 Qianjiang Biochemical
13.20.1 Qianjiang Biochemical Company Information
13.20.2 Qianjiang Biochemical Veterinary Drug Product Portfolios and Specifications
13.20.3 Qianjiang Biochemical Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Qianjiang Biochemical Main Business Overview
13.20.5 Qianjiang Biochemical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Veterinary Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Veterinary Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Veterinary Drug by Country/Region, 2020, 2024 & 2031
2.2 Veterinary Drug Segment by Type
2.2.1 Anti-Infectives
2.2.2 Anti-Inflammatory
2.2.3 Parasiticides
2.2.4 Analgesics
2.2.5 Sedatives
2.2.6 Others
2.3 Veterinary Drug Sales by Type
2.3.1 Global Veterinary Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Veterinary Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Veterinary Drug Sale Price by Type (2020-2025)
2.4 Veterinary Drug Segment by Application
2.4.1 Pets
2.4.2 Cattle
2.4.3 Poultry
2.4.4 Swine
2.4.5 Others
2.5 Veterinary Drug Sales by Application
2.5.1 Global Veterinary Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Veterinary Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Veterinary Drug Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Veterinary Drug Breakdown Data by Company
3.1.1 Global Veterinary Drug Annual Sales by Company (2020-2025)
3.1.2 Global Veterinary Drug Sales Market Share by Company (2020-2025)
3.2 Global Veterinary Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Veterinary Drug Revenue by Company (2020-2025)
3.2.2 Global Veterinary Drug Revenue Market Share by Company (2020-2025)
3.3 Global Veterinary Drug Sale Price by Company
3.4 Key Manufacturers Veterinary Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary Drug Product Location Distribution
3.4.2 Players Veterinary Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VETERINARY DRUG BY GEOGRAPHIC REGION
4.1 World Historic Veterinary Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Veterinary Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Veterinary Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Veterinary Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Veterinary Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Veterinary Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Veterinary Drug Sales Growth
4.4 APAC Veterinary Drug Sales Growth
4.5 Europe Veterinary Drug Sales Growth
4.6 Middle East & Africa Veterinary Drug Sales Growth
5 AMERICAS
5.1 Americas Veterinary Drug Sales by Country
5.1.1 Americas Veterinary Drug Sales by Country (2020-2025)
5.1.2 Americas Veterinary Drug Revenue by Country (2020-2025)
5.2 Americas Veterinary Drug Sales by Type (2020-2025)
5.3 Americas Veterinary Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Drug Sales by Region
6.1.1 APAC Veterinary Drug Sales by Region (2020-2025)
6.1.2 APAC Veterinary Drug Revenue by Region (2020-2025)
6.2 APAC Veterinary Drug Sales by Type (2020-2025)
6.3 APAC Veterinary Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Veterinary Drug by Country
7.1.1 Europe Veterinary Drug Sales by Country (2020-2025)
7.1.2 Europe Veterinary Drug Revenue by Country (2020-2025)
7.2 Europe Veterinary Drug Sales by Type (2020-2025)
7.3 Europe Veterinary Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Veterinary Drug by Country
8.1.1 Middle East & Africa Veterinary Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Veterinary Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Veterinary Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Veterinary Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Drug
10.3 Manufacturing Process Analysis of Veterinary Drug
10.4 Industry Chain Structure of Veterinary Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary Drug Distributors
11.3 Veterinary Drug Customer
12 WORLD FORECAST REVIEW FOR VETERINARY DRUG BY GEOGRAPHIC REGION
12.1 Global Veterinary Drug Market Size Forecast by Region
12.1.1 Global Veterinary Drug Forecast by Region (2026-2031)
12.1.2 Global Veterinary Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Veterinary Drug Forecast by Type (2026-2031)
12.7 Global Veterinary Drug Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Veterinary Drug Product Portfolios and Specifications
13.1.3 Zoetis Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Elanco
13.2.1 Elanco Company Information
13.2.2 Elanco Veterinary Drug Product Portfolios and Specifications
13.2.3 Elanco Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Elanco Main Business Overview
13.2.5 Elanco Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Veterinary Drug Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Veterinary Drug Product Portfolios and Specifications
13.4.3 Merck Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Virbac
13.5.1 Virbac Company Information
13.5.2 Virbac Veterinary Drug Product Portfolios and Specifications
13.5.3 Virbac Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Virbac Main Business Overview
13.5.5 Virbac Latest Developments
13.6 Ceva
13.6.1 Ceva Company Information
13.6.2 Ceva Veterinary Drug Product Portfolios and Specifications
13.6.3 Ceva Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Ceva Main Business Overview
13.6.5 Ceva Latest Developments
13.7 Vetoquinol
13.7.1 Vetoquinol Company Information
13.7.2 Vetoquinol Veterinary Drug Product Portfolios and Specifications
13.7.3 Vetoquinol Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Vetoquinol Main Business Overview
13.7.5 Vetoquinol Latest Developments
13.8 Dechra
13.8.1 Dechra Company Information
13.8.2 Dechra Veterinary Drug Product Portfolios and Specifications
13.8.3 Dechra Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Dechra Main Business Overview
13.8.5 Dechra Latest Developments
13.9 Norbrook
13.9.1 Norbrook Company Information
13.9.2 Norbrook Veterinary Drug Product Portfolios and Specifications
13.9.3 Norbrook Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Norbrook Main Business Overview
13.9.5 Norbrook Latest Developments
13.10 Phibro
13.10.1 Phibro Company Information
13.10.2 Phibro Veterinary Drug Product Portfolios and Specifications
13.10.3 Phibro Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Phibro Main Business Overview
13.10.5 Phibro Latest Developments
13.11 Huvepharma
13.11.1 Huvepharma Company Information
13.11.2 Huvepharma Veterinary Drug Product Portfolios and Specifications
13.11.3 Huvepharma Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Huvepharma Main Business Overview
13.11.5 Huvepharma Latest Developments
13.12 Hipra
13.12.1 Hipra Company Information
13.12.2 Hipra Veterinary Drug Product Portfolios and Specifications
13.12.3 Hipra Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Hipra Main Business Overview
13.12.5 Hipra Latest Developments
13.13 Ouro Fino Saude
13.13.1 Ouro Fino Saude Company Information
13.13.2 Ouro Fino Saude Veterinary Drug Product Portfolios and Specifications
13.13.3 Ouro Fino Saude Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Ouro Fino Saude Main Business Overview
13.13.5 Ouro Fino Saude Latest Developments
13.14 CAHIC
13.14.1 CAHIC Company Information
13.14.2 CAHIC Veterinary Drug Product Portfolios and Specifications
13.14.3 CAHIC Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 CAHIC Main Business Overview
13.14.5 CAHIC Latest Developments
13.15 Orion
13.15.1 Orion Company Information
13.15.2 Orion Veterinary Drug Product Portfolios and Specifications
13.15.3 Orion Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Orion Main Business Overview
13.15.5 Orion Latest Developments
13.16 Ringpu Biology
13.16.1 Ringpu Biology Company Information
13.16.2 Ringpu Biology Veterinary Drug Product Portfolios and Specifications
13.16.3 Ringpu Biology Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Ringpu Biology Main Business Overview
13.16.5 Ringpu Biology Latest Developments
13.17 Nippon Zenyaku Kogyo
13.17.1 Nippon Zenyaku Kogyo Company Information
13.17.2 Nippon Zenyaku Kogyo Veterinary Drug Product Portfolios and Specifications
13.17.3 Nippon Zenyaku Kogyo Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Nippon Zenyaku Kogyo Main Business Overview
13.17.5 Nippon Zenyaku Kogyo Latest Developments
13.18 Farmavet-Pasteur
13.18.1 Farmavet-Pasteur Company Information
13.18.2 Farmavet-Pasteur Veterinary Drug Product Portfolios and Specifications
13.18.3 Farmavet-Pasteur Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Farmavet-Pasteur Main Business Overview
13.18.5 Farmavet-Pasteur Latest Developments
13.19 Jinhe Bio
13.19.1 Jinhe Bio Company Information
13.19.2 Jinhe Bio Veterinary Drug Product Portfolios and Specifications
13.19.3 Jinhe Bio Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Jinhe Bio Main Business Overview
13.19.5 Jinhe Bio Latest Developments
13.20 Qianjiang Biochemical
13.20.1 Qianjiang Biochemical Company Information
13.20.2 Qianjiang Biochemical Veterinary Drug Product Portfolios and Specifications
13.20.3 Qianjiang Biochemical Veterinary Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Qianjiang Biochemical Main Business Overview
13.20.5 Qianjiang Biochemical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Veterinary Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Veterinary Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Anti-Infectives
Table 4. Major Players of Anti-Inflammatory
Table 5. Major Players of Parasiticides
Table 6. Major Players of Analgesics
Table 7. Major Players of Sedatives
Table 8. Major Players of Others
Table 9. Global Veterinary Drug Sales by Type (2020-2025) & (M Units)
Table 10. Global Veterinary Drug Sales Market Share by Type (2020-2025)
Table 11. Global Veterinary Drug Revenue by Type (2020-2025) & ($ million)
Table 12. Global Veterinary Drug Revenue Market Share by Type (2020-2025)
Table 13. Global Veterinary Drug Sale Price by Type (2020-2025) & (USD/Unit)
Table 14. Global Veterinary Drug Sale by Application (2020-2025) & (M Units)
Table 15. Global Veterinary Drug Sale Market Share by Application (2020-2025)
Table 16. Global Veterinary Drug Revenue by Application (2020-2025) & ($ million)
Table 17. Global Veterinary Drug Revenue Market Share by Application (2020-2025)
Table 18. Global Veterinary Drug Sale Price by Application (2020-2025) & (USD/Unit)
Table 19. Global Veterinary Drug Sales by Company (2020-2025) & (M Units)
Table 20. Global Veterinary Drug Sales Market Share by Company (2020-2025)
Table 21. Global Veterinary Drug Revenue by Company (2020-2025) & ($ millions)
Table 22. Global Veterinary Drug Revenue Market Share by Company (2020-2025)
Table 23. Global Veterinary Drug Sale Price by Company (2020-2025) & (USD/Unit)
Table 24. Key Manufacturers Veterinary Drug Producing Area Distribution and Sales Area
Table 25. Players Veterinary Drug Products Offered
Table 26. Veterinary Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Veterinary Drug Sales by Geographic Region (2020-2025) & (M Units)
Table 30. Global Veterinary Drug Sales Market Share Geographic Region (2020-2025)
Table 31. Global Veterinary Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 32. Global Veterinary Drug Revenue Market Share by Geographic Region (2020-2025)
Table 33. Global Veterinary Drug Sales by Country/Region (2020-2025) & (M Units)
Table 34. Global Veterinary Drug Sales Market Share by Country/Region (2020-2025)
Table 35. Global Veterinary Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 36. Global Veterinary Drug Revenue Market Share by Country/Region (2020-2025)
Table 37. Americas Veterinary Drug Sales by Country (2020-2025) & (M Units)
Table 38. Americas Veterinary Drug Sales Market Share by Country (2020-2025)
Table 39. Americas Veterinary Drug Revenue by Country (2020-2025) & ($ millions)
Table 40. Americas Veterinary Drug Sales by Type (2020-2025) & (M Units)
Table 41. Americas Veterinary Drug Sales by Application (2020-2025) & (M Units)
Table 42. APAC Veterinary Drug Sales by Region (2020-2025) & (M Units)
Table 43. APAC Veterinary Drug Sales Market Share by Region (2020-2025)
Table 44. APAC Veterinary Drug Revenue by Region (2020-2025) & ($ millions)
Table 45. APAC Veterinary Drug Sales by Type (2020-2025) & (M Units)
Table 46. APAC Veterinary Drug Sales by Application (2020-2025) & (M Units)
Table 47. Europe Veterinary Drug Sales by Country (2020-2025) & (M Units)
Table 48. Europe Veterinary Drug Revenue by Country (2020-2025) & ($ millions)
Table 49. Europe Veterinary Drug Sales by Type (2020-2025) & (M Units)
Table 50. Europe Veterinary Drug Sales by Application (2020-2025) & (M Units)
Table 51. Middle East & Africa Veterinary Drug Sales by Country (2020-2025) & (M Units)
Table 52. Middle East & Africa Veterinary Drug Revenue Market Share by Country (2020-2025)
Table 53. Middle East & Africa Veterinary Drug Sales by Type (2020-2025) & (M Units)
Table 54. Middle East & Africa Veterinary Drug Sales by Application (2020-2025) & (M Units)
Table 55. Key Market Drivers & Growth Opportunities of Veterinary Drug
Table 56. Key Market Challenges & Risks of Veterinary Drug
Table 57. Key Industry Trends of Veterinary Drug
Table 58. Veterinary Drug Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Veterinary Drug Distributors List
Table 61. Veterinary Drug Customer List
Table 62. Global Veterinary Drug Sales Forecast by Region (2026-2031) & (M Units)
Table 63. Global Veterinary Drug Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Americas Veterinary Drug Sales Forecast by Country (2026-2031) & (M Units)
Table 65. Americas Veterinary Drug Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. APAC Veterinary Drug Sales Forecast by Region (2026-2031) & (M Units)
Table 67. APAC Veterinary Drug Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 68. Europe Veterinary Drug Sales Forecast by Country (2026-2031) & (M Units)
Table 69. Europe Veterinary Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Middle East & Africa Veterinary Drug Sales Forecast by Country (2026-2031) & (M Units)
Table 71. Middle East & Africa Veterinary Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 72. Global Veterinary Drug Sales Forecast by Type (2026-2031) & (M Units)
Table 73. Global Veterinary Drug Revenue Forecast by Type (2026-2031) & ($ millions)
Table 74. Global Veterinary Drug Sales Forecast by Application (2026-2031) & (M Units)
Table 75. Global Veterinary Drug Revenue Forecast by Application (2026-2031) & ($ millions)
Table 76. Zoetis Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 77. Zoetis Veterinary Drug Product Portfolios and Specifications
Table 78. Zoetis Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 79. Zoetis Main Business
Table 80. Zoetis Latest Developments
Table 81. Elanco Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 82. Elanco Veterinary Drug Product Portfolios and Specifications
Table 83. Elanco Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. Elanco Main Business
Table 85. Elanco Latest Developments
Table 86. Boehringer Ingelheim Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 87. Boehringer Ingelheim Veterinary Drug Product Portfolios and Specifications
Table 88. Boehringer Ingelheim Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 89. Boehringer Ingelheim Main Business
Table 90. Boehringer Ingelheim Latest Developments
Table 91. Merck Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 92. Merck Veterinary Drug Product Portfolios and Specifications
Table 93. Merck Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 94. Merck Main Business
Table 95. Merck Latest Developments
Table 96. Virbac Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 97. Virbac Veterinary Drug Product Portfolios and Specifications
Table 98. Virbac Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 99. Virbac Main Business
Table 100. Virbac Latest Developments
Table 101. Ceva Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 102. Ceva Veterinary Drug Product Portfolios and Specifications
Table 103. Ceva Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Ceva Main Business
Table 105. Ceva Latest Developments
Table 106. Vetoquinol Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Vetoquinol Veterinary Drug Product Portfolios and Specifications
Table 108. Vetoquinol Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 109. Vetoquinol Main Business
Table 110. Vetoquinol Latest Developments
Table 111. Dechra Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 112. Dechra Veterinary Drug Product Portfolios and Specifications
Table 113. Dechra Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 114. Dechra Main Business
Table 115. Dechra Latest Developments
Table 116. Norbrook Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 117. Norbrook Veterinary Drug Product Portfolios and Specifications
Table 118. Norbrook Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 119. Norbrook Main Business
Table 120. Norbrook Latest Developments
Table 121. Phibro Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 122. Phibro Veterinary Drug Product Portfolios and Specifications
Table 123. Phibro Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 124. Phibro Main Business
Table 125. Phibro Latest Developments
Table 126. Huvepharma Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 127. Huvepharma Veterinary Drug Product Portfolios and Specifications
Table 128. Huvepharma Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 129. Huvepharma Main Business
Table 130. Huvepharma Latest Developments
Table 131. Hipra Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 132. Hipra Veterinary Drug Product Portfolios and Specifications
Table 133. Hipra Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 134. Hipra Main Business
Table 135. Hipra Latest Developments
Table 136. Ouro Fino Saude Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 137. Ouro Fino Saude Veterinary Drug Product Portfolios and Specifications
Table 138. Ouro Fino Saude Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 139. Ouro Fino Saude Main Business
Table 140. Ouro Fino Saude Latest Developments
Table 141. CAHIC Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 142. CAHIC Veterinary Drug Product Portfolios and Specifications
Table 143. CAHIC Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 144. CAHIC Main Business
Table 145. CAHIC Latest Developments
Table 146. Orion Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 147. Orion Veterinary Drug Product Portfolios and Specifications
Table 148. Orion Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 149. Orion Main Business
Table 150. Orion Latest Developments
Table 151. Ringpu Biology Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 152. Ringpu Biology Veterinary Drug Product Portfolios and Specifications
Table 153. Ringpu Biology Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 154. Ringpu Biology Main Business
Table 155. Ringpu Biology Latest Developments
Table 156. Nippon Zenyaku Kogyo Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 157. Nippon Zenyaku Kogyo Veterinary Drug Product Portfolios and Specifications
Table 158. Nippon Zenyaku Kogyo Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 159. Nippon Zenyaku Kogyo Main Business
Table 160. Nippon Zenyaku Kogyo Latest Developments
Table 161. Farmavet-Pasteur Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 162. Farmavet-Pasteur Veterinary Drug Product Portfolios and Specifications
Table 163. Farmavet-Pasteur Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 164. Farmavet-Pasteur Main Business
Table 165. Farmavet-Pasteur Latest Developments
Table 166. Jinhe Bio Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 167. Jinhe Bio Veterinary Drug Product Portfolios and Specifications
Table 168. Jinhe Bio Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 169. Jinhe Bio Main Business
Table 170. Jinhe Bio Latest Developments
Table 171. Qianjiang Biochemical Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 172. Qianjiang Biochemical Veterinary Drug Product Portfolios and Specifications
Table 173. Qianjiang Biochemical Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 174. Qianjiang Biochemical Main Business
Table 175. Qianjiang Biochemical Latest Developments
Table 1. Veterinary Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Veterinary Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Anti-Infectives
Table 4. Major Players of Anti-Inflammatory
Table 5. Major Players of Parasiticides
Table 6. Major Players of Analgesics
Table 7. Major Players of Sedatives
Table 8. Major Players of Others
Table 9. Global Veterinary Drug Sales by Type (2020-2025) & (M Units)
Table 10. Global Veterinary Drug Sales Market Share by Type (2020-2025)
Table 11. Global Veterinary Drug Revenue by Type (2020-2025) & ($ million)
Table 12. Global Veterinary Drug Revenue Market Share by Type (2020-2025)
Table 13. Global Veterinary Drug Sale Price by Type (2020-2025) & (USD/Unit)
Table 14. Global Veterinary Drug Sale by Application (2020-2025) & (M Units)
Table 15. Global Veterinary Drug Sale Market Share by Application (2020-2025)
Table 16. Global Veterinary Drug Revenue by Application (2020-2025) & ($ million)
Table 17. Global Veterinary Drug Revenue Market Share by Application (2020-2025)
Table 18. Global Veterinary Drug Sale Price by Application (2020-2025) & (USD/Unit)
Table 19. Global Veterinary Drug Sales by Company (2020-2025) & (M Units)
Table 20. Global Veterinary Drug Sales Market Share by Company (2020-2025)
Table 21. Global Veterinary Drug Revenue by Company (2020-2025) & ($ millions)
Table 22. Global Veterinary Drug Revenue Market Share by Company (2020-2025)
Table 23. Global Veterinary Drug Sale Price by Company (2020-2025) & (USD/Unit)
Table 24. Key Manufacturers Veterinary Drug Producing Area Distribution and Sales Area
Table 25. Players Veterinary Drug Products Offered
Table 26. Veterinary Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Veterinary Drug Sales by Geographic Region (2020-2025) & (M Units)
Table 30. Global Veterinary Drug Sales Market Share Geographic Region (2020-2025)
Table 31. Global Veterinary Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 32. Global Veterinary Drug Revenue Market Share by Geographic Region (2020-2025)
Table 33. Global Veterinary Drug Sales by Country/Region (2020-2025) & (M Units)
Table 34. Global Veterinary Drug Sales Market Share by Country/Region (2020-2025)
Table 35. Global Veterinary Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 36. Global Veterinary Drug Revenue Market Share by Country/Region (2020-2025)
Table 37. Americas Veterinary Drug Sales by Country (2020-2025) & (M Units)
Table 38. Americas Veterinary Drug Sales Market Share by Country (2020-2025)
Table 39. Americas Veterinary Drug Revenue by Country (2020-2025) & ($ millions)
Table 40. Americas Veterinary Drug Sales by Type (2020-2025) & (M Units)
Table 41. Americas Veterinary Drug Sales by Application (2020-2025) & (M Units)
Table 42. APAC Veterinary Drug Sales by Region (2020-2025) & (M Units)
Table 43. APAC Veterinary Drug Sales Market Share by Region (2020-2025)
Table 44. APAC Veterinary Drug Revenue by Region (2020-2025) & ($ millions)
Table 45. APAC Veterinary Drug Sales by Type (2020-2025) & (M Units)
Table 46. APAC Veterinary Drug Sales by Application (2020-2025) & (M Units)
Table 47. Europe Veterinary Drug Sales by Country (2020-2025) & (M Units)
Table 48. Europe Veterinary Drug Revenue by Country (2020-2025) & ($ millions)
Table 49. Europe Veterinary Drug Sales by Type (2020-2025) & (M Units)
Table 50. Europe Veterinary Drug Sales by Application (2020-2025) & (M Units)
Table 51. Middle East & Africa Veterinary Drug Sales by Country (2020-2025) & (M Units)
Table 52. Middle East & Africa Veterinary Drug Revenue Market Share by Country (2020-2025)
Table 53. Middle East & Africa Veterinary Drug Sales by Type (2020-2025) & (M Units)
Table 54. Middle East & Africa Veterinary Drug Sales by Application (2020-2025) & (M Units)
Table 55. Key Market Drivers & Growth Opportunities of Veterinary Drug
Table 56. Key Market Challenges & Risks of Veterinary Drug
Table 57. Key Industry Trends of Veterinary Drug
Table 58. Veterinary Drug Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Veterinary Drug Distributors List
Table 61. Veterinary Drug Customer List
Table 62. Global Veterinary Drug Sales Forecast by Region (2026-2031) & (M Units)
Table 63. Global Veterinary Drug Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Americas Veterinary Drug Sales Forecast by Country (2026-2031) & (M Units)
Table 65. Americas Veterinary Drug Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. APAC Veterinary Drug Sales Forecast by Region (2026-2031) & (M Units)
Table 67. APAC Veterinary Drug Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 68. Europe Veterinary Drug Sales Forecast by Country (2026-2031) & (M Units)
Table 69. Europe Veterinary Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Middle East & Africa Veterinary Drug Sales Forecast by Country (2026-2031) & (M Units)
Table 71. Middle East & Africa Veterinary Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 72. Global Veterinary Drug Sales Forecast by Type (2026-2031) & (M Units)
Table 73. Global Veterinary Drug Revenue Forecast by Type (2026-2031) & ($ millions)
Table 74. Global Veterinary Drug Sales Forecast by Application (2026-2031) & (M Units)
Table 75. Global Veterinary Drug Revenue Forecast by Application (2026-2031) & ($ millions)
Table 76. Zoetis Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 77. Zoetis Veterinary Drug Product Portfolios and Specifications
Table 78. Zoetis Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 79. Zoetis Main Business
Table 80. Zoetis Latest Developments
Table 81. Elanco Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 82. Elanco Veterinary Drug Product Portfolios and Specifications
Table 83. Elanco Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. Elanco Main Business
Table 85. Elanco Latest Developments
Table 86. Boehringer Ingelheim Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 87. Boehringer Ingelheim Veterinary Drug Product Portfolios and Specifications
Table 88. Boehringer Ingelheim Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 89. Boehringer Ingelheim Main Business
Table 90. Boehringer Ingelheim Latest Developments
Table 91. Merck Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 92. Merck Veterinary Drug Product Portfolios and Specifications
Table 93. Merck Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 94. Merck Main Business
Table 95. Merck Latest Developments
Table 96. Virbac Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 97. Virbac Veterinary Drug Product Portfolios and Specifications
Table 98. Virbac Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 99. Virbac Main Business
Table 100. Virbac Latest Developments
Table 101. Ceva Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 102. Ceva Veterinary Drug Product Portfolios and Specifications
Table 103. Ceva Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Ceva Main Business
Table 105. Ceva Latest Developments
Table 106. Vetoquinol Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Vetoquinol Veterinary Drug Product Portfolios and Specifications
Table 108. Vetoquinol Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 109. Vetoquinol Main Business
Table 110. Vetoquinol Latest Developments
Table 111. Dechra Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 112. Dechra Veterinary Drug Product Portfolios and Specifications
Table 113. Dechra Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 114. Dechra Main Business
Table 115. Dechra Latest Developments
Table 116. Norbrook Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 117. Norbrook Veterinary Drug Product Portfolios and Specifications
Table 118. Norbrook Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 119. Norbrook Main Business
Table 120. Norbrook Latest Developments
Table 121. Phibro Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 122. Phibro Veterinary Drug Product Portfolios and Specifications
Table 123. Phibro Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 124. Phibro Main Business
Table 125. Phibro Latest Developments
Table 126. Huvepharma Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 127. Huvepharma Veterinary Drug Product Portfolios and Specifications
Table 128. Huvepharma Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 129. Huvepharma Main Business
Table 130. Huvepharma Latest Developments
Table 131. Hipra Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 132. Hipra Veterinary Drug Product Portfolios and Specifications
Table 133. Hipra Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 134. Hipra Main Business
Table 135. Hipra Latest Developments
Table 136. Ouro Fino Saude Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 137. Ouro Fino Saude Veterinary Drug Product Portfolios and Specifications
Table 138. Ouro Fino Saude Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 139. Ouro Fino Saude Main Business
Table 140. Ouro Fino Saude Latest Developments
Table 141. CAHIC Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 142. CAHIC Veterinary Drug Product Portfolios and Specifications
Table 143. CAHIC Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 144. CAHIC Main Business
Table 145. CAHIC Latest Developments
Table 146. Orion Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 147. Orion Veterinary Drug Product Portfolios and Specifications
Table 148. Orion Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 149. Orion Main Business
Table 150. Orion Latest Developments
Table 151. Ringpu Biology Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 152. Ringpu Biology Veterinary Drug Product Portfolios and Specifications
Table 153. Ringpu Biology Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 154. Ringpu Biology Main Business
Table 155. Ringpu Biology Latest Developments
Table 156. Nippon Zenyaku Kogyo Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 157. Nippon Zenyaku Kogyo Veterinary Drug Product Portfolios and Specifications
Table 158. Nippon Zenyaku Kogyo Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 159. Nippon Zenyaku Kogyo Main Business
Table 160. Nippon Zenyaku Kogyo Latest Developments
Table 161. Farmavet-Pasteur Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 162. Farmavet-Pasteur Veterinary Drug Product Portfolios and Specifications
Table 163. Farmavet-Pasteur Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 164. Farmavet-Pasteur Main Business
Table 165. Farmavet-Pasteur Latest Developments
Table 166. Jinhe Bio Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 167. Jinhe Bio Veterinary Drug Product Portfolios and Specifications
Table 168. Jinhe Bio Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 169. Jinhe Bio Main Business
Table 170. Jinhe Bio Latest Developments
Table 171. Qianjiang Biochemical Basic Information, Veterinary Drug Manufacturing Base, Sales Area and Its Competitors
Table 172. Qianjiang Biochemical Veterinary Drug Product Portfolios and Specifications
Table 173. Qianjiang Biochemical Veterinary Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 174. Qianjiang Biochemical Main Business
Table 175. Qianjiang Biochemical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Veterinary Drug
Figure 2. Veterinary Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Veterinary Drug Sales Growth Rate 2020-2031 (M Units)
Figure 7. Global Veterinary Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Veterinary Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Veterinary Drug Sales Market Share by Country/Region (2024)
Figure 10. Veterinary Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Anti-Infectives
Figure 12. Product Picture of Anti-Inflammatory
Figure 13. Product Picture of Parasiticides
Figure 14. Product Picture of Analgesics
Figure 15. Product Picture of Sedatives
Figure 16. Product Picture of Others
Figure 17. Global Veterinary Drug Sales Market Share by Type in 2025
Figure 18. Global Veterinary Drug Revenue Market Share by Type (2020-2025)
Figure 19. Veterinary Drug Consumed in Pets
Figure 20. Global Veterinary Drug Market: Pets (2020-2025) & (M Units)
Figure 21. Veterinary Drug Consumed in Cattle
Figure 22. Global Veterinary Drug Market: Cattle (2020-2025) & (M Units)
Figure 23. Veterinary Drug Consumed in Poultry
Figure 24. Global Veterinary Drug Market: Poultry (2020-2025) & (M Units)
Figure 25. Veterinary Drug Consumed in Swine
Figure 26. Global Veterinary Drug Market: Swine (2020-2025) & (M Units)
Figure 27. Veterinary Drug Consumed in Others
Figure 28. Global Veterinary Drug Market: Others (2020-2025) & (M Units)
Figure 29. Global Veterinary Drug Sale Market Share by Application (2024)
Figure 30. Global Veterinary Drug Revenue Market Share by Application in 2025
Figure 31. Veterinary Drug Sales by Company in 2025 (M Units)
Figure 32. Global Veterinary Drug Sales Market Share by Company in 2025
Figure 33. Veterinary Drug Revenue by Company in 2025 ($ millions)
Figure 34. Global Veterinary Drug Revenue Market Share by Company in 2025
Figure 35. Global Veterinary Drug Sales Market Share by Geographic Region (2020-2025)
Figure 36. Global Veterinary Drug Revenue Market Share by Geographic Region in 2025
Figure 37. Americas Veterinary Drug Sales 2020-2025 (M Units)
Figure 38. Americas Veterinary Drug Revenue 2020-2025 ($ millions)
Figure 39. APAC Veterinary Drug Sales 2020-2025 (M Units)
Figure 40. APAC Veterinary Drug Revenue 2020-2025 ($ millions)
Figure 41. Europe Veterinary Drug Sales 2020-2025 (M Units)
Figure 42. Europe Veterinary Drug Revenue 2020-2025 ($ millions)
Figure 43. Middle East & Africa Veterinary Drug Sales 2020-2025 (M Units)
Figure 44. Middle East & Africa Veterinary Drug Revenue 2020-2025 ($ millions)
Figure 45. Americas Veterinary Drug Sales Market Share by Country in 2025
Figure 46. Americas Veterinary Drug Revenue Market Share by Country (2020-2025)
Figure 47. Americas Veterinary Drug Sales Market Share by Type (2020-2025)
Figure 48. Americas Veterinary Drug Sales Market Share by Application (2020-2025)
Figure 49. United States Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 50. Canada Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 51. Mexico Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 52. Brazil Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 53. APAC Veterinary Drug Sales Market Share by Region in 2025
Figure 54. APAC Veterinary Drug Revenue Market Share by Region (2020-2025)
Figure 55. APAC Veterinary Drug Sales Market Share by Type (2020-2025)
Figure 56. APAC Veterinary Drug Sales Market Share by Application (2020-2025)
Figure 57. China Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 58. Japan Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 59. South Korea Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 60. Southeast Asia Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 61. India Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 62. Australia Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 63. China Taiwan Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 64. Europe Veterinary Drug Sales Market Share by Country in 2025
Figure 65. Europe Veterinary Drug Revenue Market Share by Country (2020-2025)
Figure 66. Europe Veterinary Drug Sales Market Share by Type (2020-2025)
Figure 67. Europe Veterinary Drug Sales Market Share by Application (2020-2025)
Figure 68. Germany Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 69. France Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 70. UK Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 71. Italy Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 72. Russia Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. Middle East & Africa Veterinary Drug Sales Market Share by Country (2020-2025)
Figure 74. Middle East & Africa Veterinary Drug Sales Market Share by Type (2020-2025)
Figure 75. Middle East & Africa Veterinary Drug Sales Market Share by Application (2020-2025)
Figure 76. Egypt Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 77. South Africa Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 78. Israel Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 79. Turkey Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 80. GCC Countries Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of Veterinary Drug in 2025
Figure 82. Manufacturing Process Analysis of Veterinary Drug
Figure 83. Industry Chain Structure of Veterinary Drug
Figure 84. Channels of Distribution
Figure 85. Global Veterinary Drug Sales Market Forecast by Region (2026-2031)
Figure 86. Global Veterinary Drug Revenue Market Share Forecast by Region (2026-2031)
Figure 87. Global Veterinary Drug Sales Market Share Forecast by Type (2026-2031)
Figure 88. Global Veterinary Drug Revenue Market Share Forecast by Type (2026-2031)
Figure 89. Global Veterinary Drug Sales Market Share Forecast by Application (2026-2031)
Figure 90. Global Veterinary Drug Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Veterinary Drug
Figure 2. Veterinary Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Veterinary Drug Sales Growth Rate 2020-2031 (M Units)
Figure 7. Global Veterinary Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Veterinary Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Veterinary Drug Sales Market Share by Country/Region (2024)
Figure 10. Veterinary Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Anti-Infectives
Figure 12. Product Picture of Anti-Inflammatory
Figure 13. Product Picture of Parasiticides
Figure 14. Product Picture of Analgesics
Figure 15. Product Picture of Sedatives
Figure 16. Product Picture of Others
Figure 17. Global Veterinary Drug Sales Market Share by Type in 2025
Figure 18. Global Veterinary Drug Revenue Market Share by Type (2020-2025)
Figure 19. Veterinary Drug Consumed in Pets
Figure 20. Global Veterinary Drug Market: Pets (2020-2025) & (M Units)
Figure 21. Veterinary Drug Consumed in Cattle
Figure 22. Global Veterinary Drug Market: Cattle (2020-2025) & (M Units)
Figure 23. Veterinary Drug Consumed in Poultry
Figure 24. Global Veterinary Drug Market: Poultry (2020-2025) & (M Units)
Figure 25. Veterinary Drug Consumed in Swine
Figure 26. Global Veterinary Drug Market: Swine (2020-2025) & (M Units)
Figure 27. Veterinary Drug Consumed in Others
Figure 28. Global Veterinary Drug Market: Others (2020-2025) & (M Units)
Figure 29. Global Veterinary Drug Sale Market Share by Application (2024)
Figure 30. Global Veterinary Drug Revenue Market Share by Application in 2025
Figure 31. Veterinary Drug Sales by Company in 2025 (M Units)
Figure 32. Global Veterinary Drug Sales Market Share by Company in 2025
Figure 33. Veterinary Drug Revenue by Company in 2025 ($ millions)
Figure 34. Global Veterinary Drug Revenue Market Share by Company in 2025
Figure 35. Global Veterinary Drug Sales Market Share by Geographic Region (2020-2025)
Figure 36. Global Veterinary Drug Revenue Market Share by Geographic Region in 2025
Figure 37. Americas Veterinary Drug Sales 2020-2025 (M Units)
Figure 38. Americas Veterinary Drug Revenue 2020-2025 ($ millions)
Figure 39. APAC Veterinary Drug Sales 2020-2025 (M Units)
Figure 40. APAC Veterinary Drug Revenue 2020-2025 ($ millions)
Figure 41. Europe Veterinary Drug Sales 2020-2025 (M Units)
Figure 42. Europe Veterinary Drug Revenue 2020-2025 ($ millions)
Figure 43. Middle East & Africa Veterinary Drug Sales 2020-2025 (M Units)
Figure 44. Middle East & Africa Veterinary Drug Revenue 2020-2025 ($ millions)
Figure 45. Americas Veterinary Drug Sales Market Share by Country in 2025
Figure 46. Americas Veterinary Drug Revenue Market Share by Country (2020-2025)
Figure 47. Americas Veterinary Drug Sales Market Share by Type (2020-2025)
Figure 48. Americas Veterinary Drug Sales Market Share by Application (2020-2025)
Figure 49. United States Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 50. Canada Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 51. Mexico Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 52. Brazil Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 53. APAC Veterinary Drug Sales Market Share by Region in 2025
Figure 54. APAC Veterinary Drug Revenue Market Share by Region (2020-2025)
Figure 55. APAC Veterinary Drug Sales Market Share by Type (2020-2025)
Figure 56. APAC Veterinary Drug Sales Market Share by Application (2020-2025)
Figure 57. China Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 58. Japan Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 59. South Korea Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 60. Southeast Asia Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 61. India Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 62. Australia Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 63. China Taiwan Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 64. Europe Veterinary Drug Sales Market Share by Country in 2025
Figure 65. Europe Veterinary Drug Revenue Market Share by Country (2020-2025)
Figure 66. Europe Veterinary Drug Sales Market Share by Type (2020-2025)
Figure 67. Europe Veterinary Drug Sales Market Share by Application (2020-2025)
Figure 68. Germany Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 69. France Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 70. UK Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 71. Italy Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 72. Russia Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. Middle East & Africa Veterinary Drug Sales Market Share by Country (2020-2025)
Figure 74. Middle East & Africa Veterinary Drug Sales Market Share by Type (2020-2025)
Figure 75. Middle East & Africa Veterinary Drug Sales Market Share by Application (2020-2025)
Figure 76. Egypt Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 77. South Africa Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 78. Israel Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 79. Turkey Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 80. GCC Countries Veterinary Drug Revenue Growth 2020-2025 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of Veterinary Drug in 2025
Figure 82. Manufacturing Process Analysis of Veterinary Drug
Figure 83. Industry Chain Structure of Veterinary Drug
Figure 84. Channels of Distribution
Figure 85. Global Veterinary Drug Sales Market Forecast by Region (2026-2031)
Figure 86. Global Veterinary Drug Revenue Market Share Forecast by Region (2026-2031)
Figure 87. Global Veterinary Drug Sales Market Share Forecast by Type (2026-2031)
Figure 88. Global Veterinary Drug Revenue Market Share Forecast by Type (2026-2031)
Figure 89. Global Veterinary Drug Sales Market Share Forecast by Application (2026-2031)
Figure 90. Global Veterinary Drug Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Applanation Type Tonometers Market Growth 2024-2030
US$ 3,660.00
June 2024
118 pages
Global Tuberculosis Vaccine Treatment Market Growth 2025-2031
US$ 3,660.00
January 2024
124 pages
Global Urology Imaging Equipment Market Growth 2023-2029
US$ 3,660.00
February 2023
108 pages
Global Shoulder Arthroscopy Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
March 2023
85 pages
Global Neuroendocrine Carcinoma Treatment Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
December 2024
103 pages
